Cargando…
Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care
Autores principales: | Greenhawt, Matthew, Shaker, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263209/ https://www.ncbi.nlm.nih.gov/pubmed/32497713 http://dx.doi.org/10.1016/j.anai.2020.05.029 |
Ejemplares similares
-
School Attendance, Asthma Risk, and COVID-19 in Children
por: Abrams, Elissa M., et al.
Publicado: (2021) -
Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on
por: Lipworth, Brian, et al.
Publicado: (2020) -
Rethinking Opsins
por: Feuda, Roberto, et al.
Publicado: (2022) -
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World
por: Greenhawt, Matthew, et al.
Publicado: (2021) -
Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction
por: Greenhawt, Matthew, et al.
Publicado: (2019)